trending Market Intelligence /marketintelligence/en/news-insights/trending/L9pM1DPj0QNSwotNi3BS-g2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Integra LifeSciences warned by US FDA over quality concerns at Boston facility

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Integra LifeSciences warned by US FDA over quality concerns at Boston facility

The U.S. Food and Drug Administration has issued a warning letter to a unit of Integra LifeSciences Holdings Corp. regarding manufacturing processes at its Boston facility that manufactures products for use in lab tests.

Plainsboro, N.J.-based Integra said the FDA inspected the facility in October and November 2018, and quality systems issues were identified at that time. The nature of the concerns was not described in a March 11 regulatory document announcing the receipt of the warning letter. Integra, however, said the warning letter did not contain any new observations that the company had not been aware of following the inspection.

Since then, Integra has responded to the agency to detail corrective actions taken on a monthly basis, and "significant" measures have been taken to address the agency's concerns.

The facility manufactures extracellular bovine matrix products, also known as collagen, which are used for cell cultures in laboratory tests.

Integra is a healthcare equipment company that manufactures surgical implants and medical instruments, among other products.